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Abstract
Background: Children with physical disabilities may have an increased risk for obesity and obesity might be a risk
factor for inflammatory arthritis. The aims of this study were: to determine the prevalence of obesity in children
and adolescents with juvenile idiopathic arthritis (JIA), and to examine the association between obesity and disease
activity in this population.
Findings: A cross-sectional analysis of all patients with JIA attending a pediatric rheumatology clinic, between
October 2009 and September 2010, was performed. A linear regression model was used to explore the association
between obesity and disease activity in patients with JIA. A total of 154 subjects were included in the analysis;
median age was 10.6 years, 61% were female, and 88% were white. Obesity was found in 18%, 12% were
overweight, and 3% were underweight. There was no association between obesity and JADAS-27 (Juvenile Arthritis
Disease Activity Score 27), physician’s assessment of disease activity, parent’s assessment of child’s well-being,
erythrocyte sedimentation rate, number of active joints, or C-reactive protein (p-value range 0.10 to 0.95).
Conclusions: Although 18% of patients with JIA were obese, we did not find an association between obesity and
disease activity. As obesity confers an additional health risk in children with arthritis, addressing this co-morbidity
should be a health priority in patients with JIA. Future studies are necessary to further explore potential
associations between obesity, development of JIA, and disease activity.
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Background
Obesity is of epidemic proportions throughout the world
[1-3]. The prevalence estimates are even more alarming
in developed countries [1]. For example, recent data
from the CDC shows that 20,7% of schoolchildren in
New York City are obese [4-6].
Children with physical disabilities may have an
increased risk for obesity and the rates of overweight
and obesity in patients with juvenile idiopathic arthritis
(JIA) have ranged from 5 to 23% [7-10]. On the other
hand, it is possible that obesity might be a risk factor
for inflammatory arthritis. In adults, the odds of having
arthritis, other than osteoarthritis, are 4.3 higher among
the obese population [10]. A possible relationship
between adipose tissue and inflammatory arthritis is
through the role of adipokines. All major adipokines
(leptin, adiponectin, visfatin, and resistin) bear immune-
modulatory properties and evidence points to involve-
ment in the pathophysiology of rheumatoid arthritis
(RA) [11]. Studies have shown an increased level of lep-
tin (a pro-inflammatory adipokine) in the serum and in
the synovial fluid of RA patients [11]. There is also evi-
dence showing that adipocytes produce cytokines like
TNF a, IL-1 and IL-6. Besides, pathophysiology of RA
involves T cells, mast cells, and macrophages, which are
common to adipose tissue pathophysiology as well [11].
Obesity has also been associated with worse disease
activity in adults with RA [12,13]. Correlations between
leptin and disease markers like DAS-28, erythrocyte
sedimentation rate (ESR), and the number of tender
joints have been shown in patients with longer disease
duration [11].
While obesity may be a risk factor for, or a conse-
quence of arthritis, it is unknown whether it is asso-
ciated with the severity of disease activity in patients
with JIA. The objectives of this study were to determine
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examine the association between obesity and disease
activity in this population.
Methods
A database was created of all patients with JIA attending a
single pediatric rheumatology clinic in Boston, between
October/2009 and September/2010 who had blood drawn
for routine clinical monitoring. In a period of 1 year vir-
tually every patient with JIA has blood drawn at least
once. From all eligible patients, only 1 declined to be
included in the database. Patients who had taken corticos-
teroids in the previous 3 months, who were not English-
speaking, who had any infections during the 2 weeks
before the appointment, and who had concurrent medical
problems (diabetes type 1, inflammatory bowel disease,
celiac disease, and immunodeficiency) were excluded.
Body mass index (BMI), disease activity scores, and other
demographic and clinical information were retrieved from
this database. This project was approved by the Institu-
tional Review Board at Tufts Medical Center.
Disease activity was measured on the same visit of the
blood tests, using a validated score, JADAS- 27 (Juvenile
Arthritis Disease Activity Score 27) [14]. This score
includes four measures: physician global assessment of dis-
ease activity using a visual analog scale (VAS) [12], parent
global assessment of child’s well-being determined by a
VAS, count of joints with active disease (evaluating 27
joints), and ESR. ESR is normalized to a score ranging
from 0 to 10, by the formula (ESR-20)/10. JADAS-27 is
calculated as the simple linear sum of the scores of its 4
components, which yields a total score of 0-57, with higher
scores associated with worse disease activity.
BMI values were plotted using the 2000 CDC growth
charts (BMI for age) [5], and BMI percentiles were deter-
mined. Children were classified as obese if their BMI was
≥ 95
th percentile, overweight if their BMI was between
the 85
th and 94
th percentile, and healthy weight if their
BMI was between the 5
th and the 84
th percentiles [4,6].
Prevalence of underweight (BMI < 5
th percentile) was
also determined, however, there was a very small number
of patients in this category, hence they were grouped
under healthy weight for statistical analysis purposes.
Basic demographic and health information about study
subjects was also collected including the following: age,
gender, ethnicity, JIA subtype, time interval since disease
onset, current medications, and C-reactive protein value
(CRP). Medications used for JIA treatment were recorded
(non-steroidal anti-inflammatory drugs, methotrexate,
biologic drugs), as well as the duration of use of each
medication. Subjects were only considered to be on
methotrexate or a biologic drug if the duration of use
was ≥ 2 months.
Statistical analysis
The prevalence of obesity was determined. Linear regres-
sion was used to examine the association of obesity with
JADAS-27, physician VAS, parent VAS, number of active
joints, and CRP levels. Logistic regression was used to
examine the association between obesity and ESR
(dichotomized to normal, if ≤20, or abnormal). A multi-
variable linear regression model was developed to analyze
the association between obesity and the outcome JADAS-
27. The model was adjusted for potential confounders,
identified a priori,s u c ha sa g e ,g e n d e r ,J I As u b t y p e ,e t h -
nicity, medications (none, non-steroidal anti-inflamma-
tory drugs, or immunosuppressants - methotrexate and/
or biologics), and time since disease onset.
JMP version 9 (SAS Institute Inc., Cary, NC) was used
for data analyses. All tests were two-sided and statistical
significance was defined as a two-sided p-value < 0.05.
Results
A total of 154 subjects were included in the analyses.
Subjects’ characteristics are shown by BMI category in
Table 1. There were no differences in patients’ charac-
teristics by BMI category. The median age of partici-
pants’ was 10.6 years (± 4.5, range 2-19), 61% were
female, and 88% were white.
Median BMI was 19 and median BMI percentile was
67 (interquartile range 41-88). Eighteen percent of the
patients (n = 28) were obese, 12% (n = 19) were over-
weight, and 3% (n = 4) were underweight.
The score of JIA disease activity, JADAS-27, had a
median value of 5.2 (range 0-30.7). The components of
JADAS-27 and its individual scores are described by
BMI category in Table 2.
There was no association between obesity and JADAS-
27 in the univariable linear regression (beta coefficient =
0.04; 95%CI = -1.19, 1.27; p = 0.95), neither between
obesity and physician’sV A S( b e t ac o e f f i c i e n t=0 . 0 8 ;
95%CI = -0.28, 0.44; p = 0.66), parent’s VAS (beta coef-
ficient = -0.35; 95%CI = -0.77, 0.07; p = 0.10), ESR (OR
= 0.53; 95%CI = 0.21, 1.41; p = 0.18), number of active
joints (beta coefficient = 0.22; 95%CI = -0.39, 0.83; p =
0.48), or CRP (beta coefficient = 0.33; 95%CI = -1.19,
1.85; p = 0.67). In the multivariable linear regression
model, obesity did not have a significant effect on
JADAS-27 scores (beta coefficient = -0.12; 95%CI =
-1.31, 1.07; p = 0.84), after adjusting for age, gender, JIA
subtype, medication use, time since disease onset, and
ethnicity.
Discussion
Despite a high rate of obesity in this sample of patients
with JIA, there was no association between obesity and
disease activity, measured by several variables.
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sample were obese. This alarming rate is similar to the
rates of obesity previously reported in otherwise healthy
children, as well as in children with JIA [6-8].
Obesity has been associated with worse disease activity
in RA patients [12,13]. However, we did not find this
association in our sample of JIA patients. Although
there are no other published studies examining the asso-
ciation between obesity and disease activity in JIA, a
Brazilian study also failed to find any difference in med-
ian BMI percentiles between patients with active and
inactive disease [9]. In a cross-sectional study of RA
patients, an association between Health Assessment
Questionnaire results and BMI was found in the initial
analysis, but once physical activity was introduced as a
confounder, the association was lost. Hence it is possible
that the effects of inflammation on body composition
were mediated via physical (in)activity [15].
Even though body fat and obesity have been associated
with increased inflammatory markers (ESR and CRP
[12,16,17]), we did not find this association in our sam-
ple of JIA patients. Similarly, in other studies of children
Table 1 Demographic characteristics of patients by BMI category
Obesity
(n = 28)
Overweight
(n = 19)
Healthy weight
(n = 107)
P value
Age (median, IQR
a) 9, 6 - 13 10, 6 - 13 11, 7 - 15 0.23
Females % (N) 54 (15) 58 (11) 64 (68) 0.60
Ethnicity % (N) 0.42
Caucasian 93 (26) 84 (16) 87 (93)
African American 0 0 4 (4)
Hispanic 7 (2) 16 (3) 5 (6)
Asian 0 0 4 (4)
JIA subtype % (N) 0.27
Oligoarticular 36 (10) 53 (10) 47 (51)
Rheumatoid factor-negative polyarticular 21 (6) 10 (2) 23 (25)
Rheumatoid factor-positive polyarticular 0 0 4 (4)
Systemic-onset 4 (1) 5 (1) 2 (2)
Enthesitis-related arthritis 18 (5) 26 (5) 18 (19)
Psoriatic arthritis 21 (6) 5 (1) 6 (6)
Time since JIA onset in months (median, IQR
a) 28, 7 - 66 34, 4 - 61 25, 5 - 68 0.90
Medications % (N)
Non-steroidal anti-inflammatory drugs 50 (14) 58 (11) 49 (52) 0.75
Methotrexate 21 (6) 10 (2) 19 (20) 0.62
Biologics 14 (4) 16 (3) 17 (18) 0.95
Intra-articular steroids 4 (1) 0 5 (5) 0.62
None 36 (10) 37 (7) 31 (33) 0.81
Time on medications in months (mean ± SD)
Non-steroidal anti-inflammatory drugs 13 ± 34 6 ± 9 10 ± 22 0.88
Methotrexate 13 ± 42 2 ± 6 5 ± 15 0.62
Biologics 4 ± 10 4 ± 12 3 ± 9 0.98
aIQR: interquartile range
Table 2 Disease activity variables by BMI category
Obesity
(n = 28)
Overweight
(n = 19)
Healthy weight
(n = 107)
P value
C-reactive protein mg/L (mean ± SD) 2 ± 2 1 ± 2 3 ± 9 0.12
Parent VAS (median, IQR
a) 2.2, 0.8 - 4.6 1.5, 0.6 - 3.2 1.3, 0.5 - 2.6 0.24
Physician VAS (median, IQR
a) 1.3, 0 - 2.7 0.9, 0 - 2.2 1.3, 0.5 - 2.6 0.42
ESR in mm/hr (median, IQR
a) 14, 9 - 21 14, 10 - 20 10, 8 - 16 0.10
Joint count (median, IQR
a) 1.5, 0 - 4 1, 0 - 3 2, 0 - 4 0.08
JADAS - 27 (median, IQR
a) 5.6, 2.2 - 10 3.4, 1.8 - 8 5.2, 2.2 - 10.5 0.44
aIQR: interquartile range
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[9,18]. Also studies involving RA patients failed to show
an association between CRP and obesity or BMI
[13,15,19].
Interestingly, BMI increase has been associated with the
use of anti-TNF agents [20,21]. Although the role of anti-
TNF drugs on weight regulation needs to be confirmed,
one hypothesis to explain these findings is that inhibition
of TNF-a driven hypermetabolism results in weight gain
[22]. However, we did not find any differences on the rate
of use of medications in the different BMI categories.
Our study had several limitations, such as the cross-sec-
tional design, and the relatively small sample size, which
could be responsible for inadequate statistical power. We
did not have information on physical activity, socioeco-
nomic status, and parents’ education level and BMI, all of
which have been previously associated with obesity.
However, to the best of our knowledge, this is the first
study to investigate the association between obesity and
disease activity in patients with JIA.
In conclusion, although 18% of JIA patients in this study
were obese, we did not find an association between obesity
and disease activity. As obesity confers an additional
health risk in children with arthritis, addressing this co-
morbidity should be a health priority in patients with JIA.
Future studies are necessary to further explore potential
associations between obesity, development of JIA, and dis-
ease activity.
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